Akeso Biomedical, Inc.is developing a new generation of compounds, known as Fe3C, with broad-spectrum activity to fight bacterial infections, and prevent foodborne illnesses.
Member count: 11-50
Total raised: $4.4M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | VIC Techno... | victech.co... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.06.2017 | - | $4.4M | - | finsmes.co... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 25.10.2021 | Akeso Biom... | "We are very excited to b... | - | - | prweb.com/... |
| 04.12.2018 | A List of ... | Dairy production is one of the... | - | - | agfunderne... |
| 13.06.2017 | Akeso Biom... | Akeso Biomedical, Inc., a Walt... | USA | - | finsmes.co... |
| 13.06.2017 | Akeso Biom... | WALTHAM, Mass.--(BUSINESS WIRE... | - | - | citybizlis... |
| 23.12.2014 | Wound care... | The company’s lead Fe3C produc... | - | - | medcitynew... |
| - | Wound care... | Boston-area startup Akeso Biom... | - | - | medcitynew... |